In early 2020, US-based GI medical societies banded together to issue a joint statement that endorsed physical separation and wearing face masks to prevent the spread of COVID-19. Within that same year, they also listed recommendations for managing endoscopies and endoscopy processes. Since then, these societies and associations have not recommended new safety protocols for breath testing and other aerosol-generating procedures in this COVID-19 environment.
Internationally, several GI groups and associations have made strong recommendations regarding aerosol-generating procedures, including where and how breath testing should occur.
At-home breath testing is safer, healthier, and a lower-cost diagnostic plan for both patients and the facility. While some healthcare systems have already successfully transitioned their GI diagnostics to at-home breath testing, CDI along with GI leaders are calling for updated guidelines from industry medical professional societies for breath testing.
Functional GI Diagnostic Test Orders
Submit your patient diagnostic orders. We will process your order ASAP!
Latest News & Insights
The IMO Landscape: Insights from Breath Testing Research and Clinical Practice
Breath testing for methane provides indispensable insights into the presence and severity of Intestinal Methanogen Overgrowth, highlighting its critical role…
Streamlining Patient Care: Introducing CDI’s New Hydrogen and Methane Breath Test Kit Registration Process for Healthcare Providers
CDI is proud to announce the launch of our new hydrogen and methane breath test kit registration process, designed to…
Integrated Approaches to GI Health: Combining Breath Testing with Nutritional Strategies
Linking hydrogen and methane breath testing and nutritional management offers a powerful, patient-centered approach to GI health. By combining precise…